SHPMF'
s EV-to-FCF Range Over the Past 10 Years
Min: -526.74 Med: 27.01 Max: 23987.84
Current: 15.87
During the past 13 years, the highest EV-to-FCF of Shanghai Pharmaceuticals Holding Co was 23987.84. The lowest was -526.74. And the median was 27.01.
SHPMF's EV-to-FCF is ranked better than 50.67% of 75
companies
in the Medical Distribution industry
Industry Median: 15.93
vs SHPMF: 15.87
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Pharmaceuticals Holding Co (OTCPK:SHPMF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Pharmaceuticals Holding Co's PE Ratio (TTM) for today is calculated as:
Shanghai Pharmaceuticals Holding Co's share price for today is $1.46.
Shanghai Pharmaceuticals Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.220.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Shanghai Pharmaceuticals Holding Co EV-to-FCF Related Terms
Shanghai Pharmaceuticals Holding Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Pharmaceuticals Holding Co EV-to-FCF Chart
For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Pharmaceuticals Holding Co EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's EV-to-FCF falls into.
Shanghai Pharmaceuticals Holding Co's current Enterprise Value is $11,831 Mil.
Shanghai Pharmaceuticals Holding Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $705 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Pharmaceuticals Holding Co (SHPMF) has a EV-to-FCF of 16.78 as of Jul. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. This is 38% below median its historical median of 27.01. According to the industry distribution chart, Shanghai Pharmaceuticals Holding Co ranks #37 out of 75 companies in the Medical Distribution industry, placing it in the top 49.3%.
Is Shanghai Pharmaceuticals Holding Co's EV-to-FCF too high?
Shanghai Pharmaceuticals Holding Co's current EV-to-FCF of 16.78 is 38% below median its 10-year median of 27.01. The Medical Distribution industry median EV-to-FCF is 15.93. Shanghai Pharmaceuticals Holding Co's value of 16.78 is 5.3% above this industry median. Based on the distribution chart, Shanghai Pharmaceuticals Holding Co ranks #37 out of 75 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's EV-to-FCF compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Shanghai Pharmaceuticals Holding Co ranks #37 out of 75 companies for EV-to-FCF. This puts Shanghai Pharmaceuticals Holding Co in the upper half of its industry. The industry median EV-to-FCF is 15.93. Shanghai Pharmaceuticals Holding Co's value of 16.78 is 5.3% above this benchmark. While the company's 10-year median is 27.01 vs. the industry median of 15.93, Shanghai Pharmaceuticals Holding Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 15.93, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Pharmaceuticals Holding Co's current EV-to-FCF of 16.78 is 5.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 15.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Pharmaceuticals Holding Co's current EV-to-FCF is 16.78, which is 38% below median its own 10-year median of 27.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a current EV-to-FCF of 16.78. The stock's GF Value™ is $1.89, compared to a current price of $1.46 — trading 22.8% below its estimated fair value. The current EV-to-FCF is 16.78, which is 38% below median its 10-year median of 27.01 and 5.3% above the Medical Distribution industry median of 15.93. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (SHPMF), the current EV-to-FCF is 16.78 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Pharmaceuticals Holding Co (SHPMF) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued.
The current stock price of $1.46 is trading 22.8% below its estimated GF Value™ of $1.89.
Key valuation signals for SHPMF:
EV-to-FCF: 16.78 (38% below median its 10-year median of 27.01)
GF Value™: $1.89 vs. price of $1.46 (22.8% below fair value)
Industry Position: 5.3% above the Medical Distribution median (#37 of 75)
No single metric tells the full story. See the SHPMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Pharmaceuticals Holding Co Business Description
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
77GF Score
Get the complete analysis for SHPMF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHPMF has been successfully added to your 
